179
Views
1
CrossRef citations to date
0
Altmetric
Review

Association of ACE I/D, -240A > T and AT1R A1166C polymorphisms with susceptibility to breast cancer: a systematic review and meta-analysis based on 35 case-control studies

, , , , , & show all
Pages 117-135 | Received 07 Jul 2019, Accepted 17 Sep 2020, Published online: 07 Oct 2020

References

  • Elobaid, Y. E.; Aw, T. C.; Grivna, M.; Nagelkerke, N. Breast Cancer Screening Awareness, Knowledge, and Practice among Arab Women in the United Arab Emirates: A Cross-Sectional Survey. PLoS One 2014, 9, e105783. DOI: 10.1371/journal.pone.0105783.
  • Kong, F.; Liu, J.; Liu, Y.; Song, B.; Wang, H.; Liu, W. Association of Interleukin-10 Gene Polymorphisms with Breast Cancer in a Chinese Population. J. Exp. Clin. Cancer Res. 2010, 29, 72DOI: 10.1186/1756-9966-29-72.
  • Ferlay, J.; Shin, H.-R.; Bray, F.; Forman, D.; Mathers, C.; Parkin, D. M. Estimates of Worldwide Burden of Cancer in 2008: GLOBOCAN 2008. Int. J. Cancer. 2010, 127, 2893–2917. DOI: 10.1002/ijc.25516.
  • Neamatzadeh, H.; Shiryazdi, S. M.; Kalantar, S. M. BRCA1 and BRCA2 Mutations in Iranian Breast Cancer Patients: A Systematic Review. J. Res. Med. Sci. 2015, 20.
  • Forat-Yazdi, M.; Neamatzadeh, H.; Sheikhha, M. H.; Zare-Shehneh, M.; Fattahi, M. BRCA1 and BRCA2 Common Mutations in Iranian Breast Cancer Patients: A Meta Analysis. Asian Pac. J. Cancer Prev. 2015, 16,1219–1224. DOI: 10.7314/APJCP.2015.16.3.
  • Cheng, Z.; Ma, R.; Tan, W.; Zhang, L.; Tan, Q. Lack of Association between ACE Insertion/Deletion Polymorphism and Lung Cancer: A Meta-Analysis. J. Renin-Angiotensin Aldosterone Syst. 2015, 16, 453–458. DOI: 10.1177/1470320314544163.
  • Atlas, S. A. The Renin-Angiotensin Aldosterone System: Pathophysiological Role and Pharmacologic Inhibition. J. Manage. Care Pharm. 2007, 13, 9–20. DOI: 10.18553/jmcp.2007.13.s8-b.9.
  • Harrison-Bernard, L. M. The Renal Renin-Angiotensin System. Adv. Physiol. Educ. 2009, 33, 270–274. DOI: 10.1152/advan.00049.2009.
  • Dasgupta, C.; Zhang, L. Angiotensin II Receptors and Drug Discovery in Cardiovascular Disease. Drug Discov. Today. 2011, 16, 22–34. DOI: 10.1016/j.drudis.2010.11.016.
  • DerSimonian, R.; Laird, N. Meta-Analysis in Clinical Trials. Controlled Clin. Trials 1986, 7, 177–188. http://www.ncbi.nlm.nih.gov/pubmed/3802833. Accessed March 16, 2018. DOI: 10.1016/0197-2456(86)90046-2.
  • Mantel, N.; Haenszel, W. Statistical Aspects of the Analysis of Data from Retrospective Studies of Disease. J. Natl. Cancer Inst. 1959, 22, 719–748. http://www.ncbi.nlm.nih.gov/pubmed/13655060. Accessed March 16, 2018.
  • Begg, C. B.; Mazumdar, M. Operating Characteristics of a Rank Correlation Test for Publication Bias. Biometrics 1994, 50, 1088–1101. http://www.ncbi.nlm.nih.gov/pubmed/7786990. Accessed March 16, 2018. DOI: 10.2307/2533446.
  • Egger, M.; Smith, G. D.; Schneider, M.; Minder, C. Bias in Meta-Analysis Detected by a Simple, Graphical Test. BMJ (Clinical Research ed) 1997, 315, 629–634. http://www.ncbi.nlm.nih.gov/pubmed/9310563. Accessed March 16, 2018. DOI: 10.1136/bmj.315.7109.629.
  • Koh, W.-P.; Yuan, J.-M.; Sun, C.-L. Angiotensin I-Converting Enzyme (ACE) Gene Polymorphism and Breast Cancer Risk among Chinese Women in Singapore. Cancer Res. 2003, 63, 573–578. http://www.ncbi.nlm.nih.gov/pubmed/12566298 (accessed May 17, 2018).
  • Haiman, C. A.; Henderson, S. O.; Bretsky, P.; Kolonel, L. N.; Henderson, B. E. Genetic Variation in Angiotensin I-Converting Enzyme (ACE) and Breast Cancer Risk: The Multiethnic Cohort. Cancer Res. 2003, 63, 6984–6987. http://www.ncbi.nlm.nih.gov/pubmed/14583500. Accessed May 17, 2018.
  • González-Zuloeta Ladd, A. M.; Arias Vásquez, A.; Sayed-Tabatabaei, F. A.; Coebergh, J. W.; Hofman, A.; Njajou, O.; Stricker, B.; van Duijn, C. Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Breast Cancer Risk. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 2143–2146. DOI: 10.1158/1055-9965.EPI-05-0045.
  • Yaren, A.; Turgut, S.; Kursunluoglu, R.; Oztop, I.; Turgut, G.; Kelten, C.; Erdem, E. Association between the Polymorphism of the Angiotensin-Converting Enzyme Gene and Tumor Size of Breast Cancer in Premenopausal Patients. Tohoku J. Exp. Med. 2006, 210, 109–116. http://www.ncbi.nlm.nih.gov/pubmed/17023764. Accessed May 15, 2018. DOI: 10.1620/tjem.210.109.
  • Yaren, A.; Turgut, S.; Kursunluoglu, R.; Oztop, I.; Turgut, G.; Degirmencioglu, S.; Kelten, C.; Erdem, E. Insertion/Deletion Polymorphism of the Angiotensin I-Converting Enzyme Gene in Patients with Breast Cancer and Effects on Prognostic Factors. J. Invest. Med. 2007, 55, 255–261. DOI: 10.2310/6650.2007.00006.
  • van der Knaap, R.; Siemes, C.; Coebergh, J.-W. W.; van Duijn, C. M.; Hofman, A.; Stricker, B. H. C. Renin-Angiotensin System Inhibitors, Angiotensin I-Converting Enzyme Gene Insertion/Deletion Polymorphism, and Cancer. Cancer 2008, 112, 748–757. DOI: 10.1002/cncr.23215.
  • Alves Corrêa, S. A.; Ribeiro de Noronha, S. M.; Nogueira-de-Souza, N. C.; Valleta de Carvalho, C.; Massad Costa, A. M.; Juvenal Linhares, J.; Vieira Gomes, M. T.; Guerreiro da Silva, I. D. C. Association between the Angiotensin-Converting Enzyme (Insertion/Deletion) and Angiotensin II Type 1 Receptor (A1166C) Polymorphisms and Breast Cancer among Brazilian Women. J. Renin-Angiotensin Aldosterone Syst. 2009, 10, 51–58. DOI: 10.1177/1470320309102317.
  • Namazi, S.; Monabati, A.; Ardeshir-Rouhani-Fard, S.; Azarpira, N. Association of Angiotensin I Converting Enzyme (Insertion/Deletion) and Angiotensin II Type 1 Receptor (A1166C) Polymorphisms with Breast Cancer Prognostic Factors in Iranian Population. Mol. Carcinog. 2010, 49, 1022–1030. DOI: 10.1002/mc.20685.
  • Siddiqi, M. A.; Syeed, N.; Abdullah, S.; Sameer, A.; Husain, S.; Nisar, S.; Rasool, A. ACE Gene Polymorphism in Breast Cancer Patients of Ethnic Kashmiri Population. Chron. Young Sci. 2010, 1, 40. DOI: 10.4103/2229-5186.76986.
  • Mendizábal-Ruiz, A. P.; Morales, J.; Castro Martinez, X.; Gutierrez Rubio, S. A.; Valdez, L.; Vásquez-Camacho, J. G.; Sanchez Corona, J.; Moran Moguel, M. C. RAS Polymorphisms in Cancerous and Benign Breast Tissue. J. Renin-Angiotensin Aldosterone Syst. 2011, 12, 85–92. DOI: 10.1177/1470320310383735.
  • Felipe, A.; Loango, N.; Ruíz, B.; Landázuri, P. Asociación Entre Los Polimorfismos de Los Genes de La Enzima Convertidora de Angiotensina y Los Receptores AT1R y AT2R y El Cáncer de Mama. Estudio de Casos y Controles, 2011; Vol 62. http://www.scielo.org.co/scielo.php?script=sci_abstract&pid=S0034-74342011000100004&lng=e&nrm=iso&tlng=es (accessed May 17, 2018).
  • Fishchuk, L. E.; Gorovenko, N. G. Genetic Polymorphisms of the Renin-Angiotensin System in Breast Cancer Patients. Exp. Oncol. 2013, 35, 101–104. http://www.ncbi.nlm.nih.gov/pubmed/23828384 (accessed May 15, 2018).
  • Xiaomei, P.; Halmurat, U.; Manshu, S.; Dilnur, M.; Dolikun, M. Polymorphism and Susceptibility of Angiotensin Converting Enzyme (ACE) Gene to Breast Cancer with Abnormal Hilit. Sci. Technol. Rev. 2014, 32, 65–68. DOI: 10.3981/J.ISSN.1000-7857.2014.36.010.
  • El Sharkawy, R. M.; Zaki, A. M.; El Fattah Kamel, A. A.; Bedair, R. N.; Ahmed, A. S. Association between the Polymorphisms of Angiotensin Converting Enzyme (Peptidyl-Dipeptidase A) INDEL Mutation (I/D) and Angiotensin II Type I Receptor (A1166C) and Breast Cancer among Post Menopausal Egyptian Females. Alexandria J. Med. 2014, 50, 267–274. DOI: 10.1016/j.ajme.2013.10.002.
  • Ghosh Roy, A.; Purkait, P.; Raha, O. Association between the Polymorphism of the Angiotensin - Converting Enzyme Gene and Breast Cancer Risk among the Bengalee Caste Hindu Females of West Bengal. Int. J. Forensic Sci. Pathol. 2015, 85–88. DOI: 10.19070/2332-287X-1500021.
  • Kumar, S.; Rizwan Hussain, S.; Waseem, M.; Mahdi, F.; Bansal, C.; Kaleem Ahmad, M. D Allele Frequency in Insertion/Deletion Polymorphism of the Angiotensin Converting Enzyme (ACE) Gene is Associated with Development of Breast Cancer Risk in Indian Women. Curr. Proteomics. 2016, 13, 297–304. DOI: 10.2174/1570164613666160902125913.
  • Singh, A.; Srivastava, N.; Amit, S.; Prasad, S. N.; Misra, M. P.; Ateeq, B. Association of AGTR1 (A1166C) and ACE (I/D) Polymorphisms with Breast Cancer Risk in North Indian Population. Transl. Oncol. 2018, 11, 233–242. DOI: 10.1016/j.tranon.2017.12.007.
  • Ding, P.; Yang, Y.; Ding, S.; Sun, B. Synergistic Association of Six Well-Characterized Polymorphisms in Three Genes of the Renin-Angiotensin System with Breast Cancer among Han Chinese Women. J. Renin-Angiotensin Aldosterone Syst. 2015, 16, 1232–1239. DOI: 10.1177/1470320314542828.
  • Wajchenberg, M.; Luciano R de, P.; Araújo, R. C.; Martins, D. E.; Puertas, E. B.; Almeida, S. S. Polymorphism of the Ace Gene and the α-Actinin-3 Gene in Adolescent Idiopathic Scoliosis. Acta Ortop. Bras. 2013, 21, 170–174. DOI: 10.1590/S1413-78522013000300009.
  • Ceolotto, G.; Papparella, I.; Bortoluzzi, A.; Strapazzon, G.; Ragazzo, F.; Bratti, P.; Fabricio, A. S. C.; Squarcina, E.; Gion, M.; Palatini, P.; et al. Interplay between miR-155, AT1R A1166C Polymorphism, and AT1R Expression in Young Untreated Hypertensives. Am. J. Hypertens. 2011, 24, 241–246. DOI: 10.1038/ajh.2010.211.
  • Liu, D.-X.; Zhang, Y.-Q.; Hu, B.; Zhang, J.; Zhao, Q. Association of AT1R Polymorphism with Hypertension Risk: An Update Meta-Analysis Based on 28,952 Subjects. J. Renin-Angiotensin Aldosterone Syst. 2015, 16, 898–909. DOI: 10.1177/1470320315584096.
  • Zhang, Y.; He, J.; Deng, Y.; Zhang, J.; Li, X.; Xiang, Z.; Huang, H.; Tian, C.; Huang, J.; Fan, H.; et al. The Insertion/Deletion (I/D) Polymorphism in the Angiotensin-Converting Enzyme Gene and Cancer Risk: A Meta-Analysis. BMC Med. Genet. 2011, 12, 159. DOI: 10.1186/1471-2350-12-159.
  • Sun, M.; Liu, C.; Wei, F.; Zhong, J.; Sun, Y. Association of Angiotensin I Converting Enzyme Insertion/Deletion Polymorphism with Breast Cancer: A Meta-Analysis. J. Renin- Angiotensin Aldosterone Syst. 2011, 12, 611–616. DOI: 10.1177/1470320311405699.
  • Xi, B.; Zeng, T.; Liu, L.; Liang, Y.; Liu, W.; Hu, Y.; Li, J. Association between Polymorphisms of the Renin-Angiotensin System Genes and Breast Cancer Risk: A Meta-Analysis. Breast Cancer Res. Treat. 2011, 130, 561–568. DOI: 10.1007/s10549-011-1602-3.
  • Pei, X.-H.; Li, H.-X. Insertion/Deletion (I/D) in the Angiotensin-Converting Enzyme Gene and Breast Cancer Risk: Lack of Association in a Meta- Analysis. Asian Pac. J. Cancer Prev. 2012, 13, 5633–5636. http://www.ncbi.nlm.nih.gov/pubmed/23317229. Accessed May 16, 2018.
  • Li, X.-L.; Zheng, Z.-J.; Qu, H.-O. Lack of Association of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism with Breast Cancer: An Update Meta-Analysis Based on 10405 Subjects. J. Renin-Angiotensin Aldosterone Syst. 2015, 16, 1095–1100. DOI: 10.1177/1470320314529357.
  • Li, L.; Wang, F.; Lv, P. W.; Zhu, M. Z.; He, J. J.; Guo, G. C.; Gu, Y. T.; Han, M. L. Angiotensin II Type 1 Receptor Gene A1166C Polymorphism and Breast Cancer Susceptibility. Genet. Mol. Res. 2015, 14, 15016–15023. DOI: 10.4238/2015.November.24.9.
  • Chen, F.; Chen, G.; Dou, Y.; Xu, X. Association of Angiotensin ІІ Type 1 Receptor (A1166C) Polymorphism with Breast Cancer Risk: An Update Meta-Analysis. J. Renin-Angiotensin Aldosterone Syst. 2015, 16, 851–857. DOI: 10.1177/1470320315588234.
  • Glasziou, P. P.; Sanders, S. L. Investigating Causes of Heterogeneity in Systematic Reviews. Stat. Med. 2002, 21, 1503–1511. DOI: 10.1002/sim.1183.
  • Ferdosian, F.; Jarahzadeh, M. H.; Bahrami, R.; et al. Association of IL-6 -174G > C Polymorphism with Susceptibility to Childhood Sepsis: A Systematic Review and Meta-Analysis. Fetal Pediatr. Pathol. 2020, 1–15. DOI: 10.1080/15513815.2020.1723149.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.